In a pivotal move to enhance diabetes care across India, Abbott and MSD Pharmaceuticals have entered into a distribution partnership aimed at expanding access to key oral anti-diabetic medications. Under this agreement, Abbott will manage the distribution of MSD’s sitagliptin-based portfolio—including Januvia, Janumet, and Janumet XR—leveraging its vast reach and deep engagement in India's healthcare system.